+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Felbamate"

Grand Mal Seizure Treatment Global Market Report 2024 - Product Thumbnail Image

Grand Mal Seizure Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
The Treatment of Epilepsy. 3rd Edition - Product Thumbnail Image

The Treatment of Epilepsy. 3rd Edition

  • Book
  • July 2009
  • 1116 Pages
  • 5 Results (Page 1 of 1)
Loading Indicator

Felbamate is a drug used to treat epilepsy and other seizure disorders. It is classified as an anticonvulsant and is used to reduce the frequency and severity of seizures. It is also used to treat Lennox-Gastaut syndrome, a rare form of epilepsy. Felbamate is a central nervous system (CNS) drug, meaning it acts on the brain and spinal cord to reduce the frequency and severity of seizures. It is usually prescribed in combination with other anticonvulsants, such as phenytoin or valproic acid. Felbamate is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 1993. It is not widely used, as it is more expensive than other anticonvulsants and has been linked to rare but serious side effects. Despite this, it is still prescribed to some patients who have not responded to other treatments. The felbamate market is relatively small, with only a few companies producing the drug. These include Mylan Pharmaceuticals, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more